
Sponsored
Advertisement


Advertisement




Advertisement

The emergence of hospital- and community-based MRSA and other resistant gram-positive pathogens have made ABSSSI a critical public health challenge.

As current antibiotics become less effective due to bacterial resistance, there is high demand for new and effective therapies with both IV and oral formulations.
Advertisement
Advertisement
Trending on Contagion Live
1
US Influenza Activity Accelerates Into the New Year as Hospitalizations Rise
2
Top Infectious Disease News Stories Week of December 27 - January 2
3
Increasing PPE Standards to Protect Patients, Healthcare Workers
4
Growing International Evidence Suggests Emerging Metallo-β-Lactamase Therapy Could Benefit US Clinicians
5